drugset / Trial / NCT00506844
Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study is to estimate the pathologic complete response rate of cetuximab, irinotecan, and capecitabine concurrent with radiotherapy given preoperatively in patients with resectable rectal cancer.
Timeline
- Start
- 2006-05
- Primary completion
- —
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 825 mg/m2 | Oral |
| Subject | Cetuximab | Monoclonal antibody | 250 mg/m2 | Intravenous |
| Subject | Irinotecan | Small molecule | 40 mg/m2 | Intravenous |